The European Union fined Israel’s Teva Pharmaceutical 462.6 million euros, saying it abused its market position in a way that might have delayed competitors from entering the multiple sclerosis market.
Related Posts
Kingfisher Narrows Profit Forecast After Sales Miss
Kingfisher said recent political and macroeconomic events are adding further uncertainty to its outlook after it posted worse-than-expected quarterly sales and narrowed down its profit […]
GSK Slumps After CDC Narrows Age Recommendation for RSV Shots
GSK shares fell more than 5% after U.S. health officials narrowed their recommendation of respiratory syncytial virus vaccines to a smaller age range and more […]
Grindr to Delve Into Dating as More Users Seek Long-Term Relationships
Grindr is planning to add several new features to its app. The additions include using AI to identify users with shared interests.